Aspire Biopharma Holdings Inc [NASDAQ: ASBP] gained 1.05% on the last trading session, reaching $0.11 price per share at the time.
Aspire Biopharma Holdings Inc represents 49.53 million in outstanding shares, while the company has a total market value of $5.26 million with the latest information. ASBP stock price has been found in the range of $0.1038 to $0.158.
If compared to the average trading volume of 27.40M shares, ASBP reached a trading volume of 539769217 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Trading performance analysis for ASBP stock
Aspire Biopharma Holdings Inc [ASBP] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -55.73. With this latest performance, ASBP shares dropped by -66.72% in over the last four-week period, additionally sinking by -57.31% over the last 6 months – not to mention a drop of -99.08% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ASBP stock in for the last two-week period is set at 25.76, with the RSI for the last a single of trading hit 0.0575, and the three-weeks RSI is set at 0.0603 for Aspire Biopharma Holdings Inc [ASBP]. The present Moving Average for the last 50 days of trading for this stock 0.3432, while it was recorded at 0.1178 for the last single week of trading, and 1.2254 for the last 200 days.
Aspire Biopharma Holdings Inc [ASBP]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Aspire Biopharma Holdings Inc [ASBP] shares currently have an operating margin of -901693.30% and a Gross Margin at 45.54%.
Aspire Biopharma Holdings Inc (ASBP) Capital Structure & Debt Analysis
Aspire Biopharma Holdings Inc (ASBP) Efficiency & Liquidity Metrics
Aspire Biopharma Holdings Inc (ASBP) Efficiency & Liquidity Metrics
An analysis of Institutional ownership at Aspire Biopharma Holdings Inc [ASBP]
There are presently around $6.48%, or 11.80%% of ASBP stock, in the hands of institutional investors.
